Galmed Pharmaceuticals
NASDAQ: GLMDTel Aviv · Founded 2013 · Israel corporation · 1 known investors
Find your way into Galmed Pharmaceuticals
Galmed is a pharmaceutical company developing metabolic and inflammatory therapeutic drugs through discovery and clinical trial phases.
Founders & leadership
RO
Ran OrenNamed on SEC filing
TG
Tali GorfineNamed on SEC filing
CB
Carol BrosgartNamed on SEC filing
YS
Yohai StenzlerNamed on SEC filing
LH
Liat HayardenyNamed on SEC filing
SN
Shmuel NirNamed on SEC filing
WM
William MarthNamed on SEC filing
AB
Allen BaharaffNamed on SEC filing
CH
Chaim HurvitzNamed on SEC filing
TY
Tali Yaron-EldarNamed on SEC filing
Board
DS
Investors · 1
Reported raises · per SEC filings
Form D private placements$100K disclosed across 1 round · 2017
▶$100KraisedAug 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$100KraisedAug 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ran OrenDirector
- Tali GorfineExecutive Officer
- Carol BrosgartDirector
- David SidranskyDirector
- Yohai StenzlerExecutive Officer
- Liat HayardenyExecutive Officer
- Shmuel NirDirector
- William MarthDirector
- Allen BaharaffExecutive Officer, Director
- Chaim HurvitzDirector
- Tali Yaron-EldarDirector
- Offering amount
- $350K
- Amount sold
- $100K
- First sale
- Aug 2017
- Incorporated
- Corporation, Israel, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Galmed Pharmaceuticals do?
- Galmed is a pharmaceutical company developing metabolic and inflammatory therapeutic drugs through discovery and clinical trial phases.
- Who are Galmed Pharmaceuticals's investors?
- Galmed Pharmaceuticals's investors include Israel Biotech Fund.
- How much funding has Galmed Pharmaceuticals raised?
- Galmed Pharmaceuticals has disclosed $100K raised across 1 round.
- Where is Galmed Pharmaceuticals headquartered?
- Galmed Pharmaceuticals is headquartered in Tel Aviv.